About
EPISEEK
Solutions
- Firefighters
Resources
- News
Contact
Download Test Order Form

Order Tests Now

National Cancer Center $397,000 Grant

by pesbm-sam | Feb 1, 2022 | Industry | 0 comments

The National Cancer Institute awards $397,000 grant to Precision Epigenomics

Search

Recent Posts

New Clinical Test Developed to Accurately Classify Pleural Effusions
Precision Epigenomics: Tactical Steps in Multi-Cancer Early Detection and Beyond
Precision Epigenomics Joins the Conversation: Key Takeaways from Rosetta Fest
Precision Epigenomics Named “Startup of the Year” by University of Arizona, Honored for Pioneering Early Cancer Detection Technology
Precision Epigenomics Announces Nannon Roosa, PMP, CPA, FACMPE, as Vice President, Technology Licensing Strategy

Recent Comments

No comments to show.

The EPISEEK^® test is recommended for use in adults with an elevated risk for cancer, such as those aged 45 or older. The EPISEEK test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. EPISEEK is intended to detect cancer signals. Use of EPISEEK is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.

Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of Cancer Signal Not Detected does not completely rule out cancer. A test result of Abnormal Methylation Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm or exclude the presence of cancer.

If cancer is not confirmed with further testing, it could mean that cancer is not present (i.e. EPISEEK false positive) or confirmatory testing was insufficient to detect a very early cancer (follow up testing false negative). False positive (abnormal methylation signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.

Quick Links

Home
About
Tests
Resources
News
Contact

Other Pages

Privacy Policy
Terms & Conditions
FCOI

Contact Info



630 N Alvernon Way
Ste 280B
Tucson, AZ 85711



520.372.7522



520.777.7367